At a glance

ClinicalIndex Comparison Record

N/ACompleted· 309 enrolled

Drug / intervention

Continuation of CRT +1 moredevice

Likely dose

Not stated in record

Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00318357

NCT00318357N/ACompleted

Compare CT.gov

CARE-HF LTFU: CArdiac REsynchronization in Heart Failure Long-term Follow-up

Medtronic Cardiac Rhythm and Heart Failure·observational·Posted Apr 26, 2006·Updated Jul 2, 2025

In Brief

An observational study evaluating Continuation of CRT and Upgrade to CRT for Heart Failure. Completed, enrolled 309 participants across 1 site.

Detailed Summary

The CARE-HF long-term follow-up trial evaluates the effects of cardiac resynchronization (CR) therapy on the mortality of patients from the CARE-HF program for an additional 4 year follow-up. Investigators are free to choose whatever available treatment they believe is in the patient's best interest.

Study Details

Study Typeobservational

Allocation--

Masking--

Primary Purpose--

ConditionsHeart Failure

CountriesUnited Kingdom

CollaboratorsMedtronic

Timeline

N/ACompletedFinished

2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027

First PostedApr 2006

Enrollment StartSep 2006

Primary CompletionSep 2010

TodayJul 2026

First PostedApr 26, 2006

Enrollment StartSep 1, 2006

Primary CompletionSep 1, 2010

TodayJul 2, 2026

Enrollment to primary: 4 yearsPosted 20.2 years ago

Interventions

Continuation of CRTdevice

Implantation of CRT device and medical treatment according normal hospital routine.

Upgrade to CRTdevice

Recommended implantation of a Medtronic CRT InSync® family devices. Implantation of CRT device and medical treatment according normal hospital routine.